Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EMA Taking Steps To Mitigate ‘Critical’ Product Shortages Due To GMP Problems

Executive Summary

The EMA is consulting on changes to the template for declaring non-compliance with good manufacturing practice, as the first step in a revision of the procedures for handling GMP-related shortages of “critical” medicines.

You may also be interested in...



‘Unacceptable’ Medicine Shortages Lead French Senate To Set Up Task Force

Medicine shortages are under scrutiny at national and EU level. In France, a newly established Senate task force is hearing evidence from a range of stakeholders including industry and regulators.

EU Survey Shows Wide Variations In How Countries Deal With Drug Shortages

A survey of EU member states has shown wide variations in the way that they deal with shortages and discontinuation of medicines.

French To Import Czech Version Of Sandoz’ Penicillin For Syphilis Amid Global Shortage

The French regulator has announced that it is importing supplies of Sandoz’ penicillin product benzathine benzylpenicillin as a result of shortages of the product. The French situation reflects a wider problem with supply of the product at the global level due to GMP issues and the shrinking number of API manufacturers.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS122851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel